BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1803887)

  • 21. [MRI diagnosis of sinus cavernous invasion by pituitary adenomas].
    Moreau L; Cottier JP; Bertrand P; Destrieux C; Jan M; Sonier CB; Herbreteau D; Rouleau P
    J Radiol; 1998 Mar; 79(3):241-6. PubMed ID: 9757244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Imaging of pituitary adenomas].
    Bonneville JF; Cattin F; Bonneville F
    Presse Med; 2009 Jan; 38(1):84-91. PubMed ID: 18990539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas.
    Nakamura T; Schörner W; Bittner RC; Felix R
    Neuroradiology; 1988; 30(6):481-6. PubMed ID: 3226534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferation, vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas.
    Iuchi T; Saeki N; Osato K; Yamaura A
    Acta Neurochir (Wien); 2000; 142(12):1345-51. PubMed ID: 11214627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR imaging of pituitary adenomas with sphenoid sinus invasion: characteristic MR findings indicating fibrosis.
    Ishii K; Ikeda H; Takahashi S; Matsumoto K; Ishibashi T; Tazawa S
    Radiat Med; 1996; 14(4):173-8. PubMed ID: 8916258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferation in pituitary adenomas: measurement by MAb KI 67.
    Kitz K; Knosp E; Koos WT; Korn A
    Acta Neurochir Suppl (Wien); 1991; 53():60-4. PubMed ID: 1803886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intracavernous invagination of pituitary macro-adenomas].
    Roux FX; Kalamarides M; Devaux B; Leriche B; Nataf F; Brami F; Meder JF; Destrieux C; Santini JJ
    Ann Endocrinol (Paris); 1996; 57(5):403-10. PubMed ID: 8991104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of normal perisellar anatomy in 1.5 T T2-weighted MRI and comparison with the anatomic criteria defining cavernous sinus invasion of pituitary adenomas.
    Knappe UJ; Jaursch-Hancke C; Schönmayr R; Lörcher U
    Cent Eur Neurosurg; 2009 Aug; 70(3):130-6. PubMed ID: 19701871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cavernous sinus invasion by pituitary adenoma: MR imaging.
    Cottier JP; Destrieux C; Brunereau L; Bertrand P; Moreau L; Jan M; Herbreteau D
    Radiology; 2000 May; 215(2):463-9. PubMed ID: 10796926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Transsphenoidal surgery of secretory and invasive pituitary adenomas (somatotropinoma or corticotropinoma)--own experiences].
    Zieliński G; Podgórski JK; Koziarski A; Potakiewicz Z; Warczyńska A; Zgliczyński W; Makowska A
    Przegl Lek; 2004; 61(9):928-34. PubMed ID: 15803901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MR-appearance of the pituitary gland before and after resection of pituitary macroadenomas.
    Steiner E; Math G; Knosp E; Mostbeck G; Kramer J; Herold CJ
    Clin Radiol; 1994 Aug; 49(8):524-30. PubMed ID: 7955862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intracavernous extension of hypophyseal macroadenomas: infiltration or invagination?].
    Roux FX; Obreja C; Moussa R; Devaux B; Nataf F; Turak B; Page P; Meder JF
    Neurochirurgie; 1998 Dec; 44(5):344-51. PubMed ID: 9915015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients.
    Del Basso De Caro M; Solari D; Pagliuca F; Villa A; Guadagno E; Cavallo LM; Colao A; Pettinato G; Cappabianca P
    Neurosurg Rev; 2017 Jan; 40(1):105-114. PubMed ID: 27215912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-operative MRI predictors of hormonal remission status post pituitary adenoma resection.
    Braileanu M; Hu R; Hoch MJ; Mullins ME; Ioachimescu AG; Oyesiku NM; Pappy A; Saindane AM
    Clin Imaging; 2019; 55():29-34. PubMed ID: 30731423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of intraoperative and imaging features of invasive growth in pituitary adenomas.
    Hladik M; Nasi-Kordhishti I; Dörner L; Kandilaris K; Schittenhelm J; Bender B; Honegger J; Behling F
    Eur J Endocrinol; 2024 Jun; 190(6):489-500. PubMed ID: 38798200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic endonasal transsellar approach for laterally extended pituitary adenomas: volumetric analysis of cavernous sinus invasion.
    Taniguchi M; Hosoda K; Akutsu N; Takahashi Y; Kohmura E
    Pituitary; 2015 Aug; 18(4):518-24. PubMed ID: 25261331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative assessment of the results of different surgical treatments in patients with pituitary adenomas infiltrating the cavernous sinus].
    Kadashev BA; Kutin MA; Kalinin PL; Trunin IuK; Alekseev SN; Shkarubo AN
    Zh Vopr Neirokhir Im N N Burdenko; 2004; (3):14-7; discussion 17. PubMed ID: 15490633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gd-DTPA-enhanced MR imaging of pituitary adenomas.
    Newton DR; Dillon WP; Norman D; Newton TH; Wilson CB
    AJNR Am J Neuroradiol; 1989; 10(5):949-54. PubMed ID: 2505539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gadolinium-DTPA and MR imaging of pituitary adenoma: a preliminary report.
    Davis PC; Hoffman JC; Malko JA; Tindall GT; Takei Y; Avruch L; Braun IF
    AJNR Am J Neuroradiol; 1987; 8(5):817-23. PubMed ID: 3118674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI of pituitary adenomas in acromegaly.
    Marro B; Zouaoui A; Sahel M; Crozat N; Gerber S; Sourour N; Sag K; Marsault C
    Neuroradiology; 1997 Jun; 39(6):394-9. PubMed ID: 9225316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.